Education
About Us
Working with TipRanks
Follow Us
Charlotte's Web Holdings (OTC) (TSE:CWEB)
:CWEB
RESEARCH TOOLSreports
CWEB Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.28
Previous CloseN/A
Volume4.38K
Average Volume (3M)19.13K
Market Cap
C$20.62M
Enterprise ValueC$69.63M
Total Cash (Recent Filing)C$22.62M
Total Debt (Recent Filing)$59.34M
Price to Earnings (P/E)―
Beta0.73
Next Earnings
Aug 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding158,617,770
10 Day Avg. Volume9,821
30 Day Avg. Volume19,125
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.02
Price to Sales (P/S)0.00
P/FCF Ratio-14.15
Enterprise Value/Market Cap3.38
Enterprise Value/Revenue0.32
Enterprise Value/Gross Profit3.28
Enterprise Value/Ebitda-0.67
Forecast
1Y Price Target
C$0.50Price Target Upside286.93% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Charlotte's Web Holdings News
PremiumCompany Announcements
Charlotte’s Web Holdings Announces 2025 Shareholder Meeting Results
PremiumCompany Announcements
Charlotte’s Web Launches Brightside™: A New Era in Hemp-Derived THC Wellness
PremiumCompany Announcements
Charlotte’s Web Holdings Reports Revenue Growth and Strategic Expansion
PremiumCompany Announcements
Charlotte’s Web Holdings: Earnings Call Insights
PremiumCompany Announcements
Charlotte’s Web Reports Strategic Growth and Cost Optimization
PremiumCompany Announcements
Charlotte’s Web Holdings Reports Strong 2024 Growth and Strategic ExpansionOptions Prices
Currently, No data available
---
Ownership Overview
1.71% Insiders
―
Mutual Funds
― Other Institutional Investors
96.59% Public Companies and Individual Investors
CWEB FAQ
What was Charlotte's Web Holdings (OTC)’s price range in the past 12 months?
Charlotte's Web Holdings (OTC) lowest stock price was C$0.07 and its highest was C$0.28 in the past 12 months.
What is Charlotte's Web Holdings (OTC)’s market cap?
Charlotte's Web Holdings (OTC)’s market cap is C$20.62M.
When is Charlotte's Web Holdings (OTC)’s upcoming earnings report date?
Charlotte's Web Holdings (OTC)’s upcoming earnings report date is Aug 07, 2025 which is in 40 days.
How were Charlotte's Web Holdings (OTC)’s earnings last quarter?
Charlotte's Web Holdings (OTC) released its earnings results on May 14, 2025. The company reported -C$0.056 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.056.
Is Charlotte's Web Holdings (OTC) overvalued?
According to Wall Street analysts Charlotte's Web Holdings (OTC)’s price is currently Undervalued.
Does Charlotte's Web Holdings (OTC) pay dividends?
Charlotte's Web Holdings (OTC) does not currently pay dividends.
What is Charlotte's Web Holdings (OTC)’s EPS estimate?
Charlotte's Web Holdings (OTC)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Charlotte's Web Holdings (OTC) have?
Charlotte's Web Holdings (OTC) has 158,617,770 shares outstanding.
What happened to Charlotte's Web Holdings (OTC)’s price movement after its last earnings report?
Charlotte's Web Holdings (OTC) reported an EPS of -C$0.056 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 12%.
Which hedge fund is a major shareholder of Charlotte's Web Holdings (OTC)?
Currently, no hedge funds are holding shares in TSE:CWEB
Company Description
Charlotte's Web Holdings (OTC)
Charlotte's Web Holdings, Inc. (CWEB) is a market leader in the production and distribution of hemp-derived cannabidiol (CBD) wellness products. Founded in 2013 and headquartered in Boulder, Colorado, the company focuses on the development of high-quality CBD products, including oils, capsules, topicals, and pet products. Charlotte's Web is committed to improving health and wellness through the power of botanicals, and it operates within the natural health and wellness sector.
CWEB Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted several positive developments, including a return to quarterly revenue growth, successful product expansion, and significant cost reductions. However, ongoing challenges, such as a year-over-year revenue decline, reduced gross margins, and regulatory hurdles, were also evident. The company is optimistic about its strategic initiatives and future growth, yet it acknowledges the need to address current headwinds.Read More>Technical Analysis
Rubicon Organics
―
Vext Science
―
Avicanna
―
C21 Investments
―
Greenway Greenhouse Cannabis Corp.
―